general news

US Prostate Cancer Nuclear Medicine Diagnostics Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2027

The US Prostate Cancer Nuclear Medicine Diagnostics Market report upholds the future market predictions related to US Prostate Cancer Nuclear Medicine Diagnostics market size, revenue, production, Consumption, gross margin and other substantial factors. It also examines the role of the prominent US Prostate Cancer Nuclear Medicine Diagnostics market players involved in the industry including their corporate overview. While emphasizing the key driving factors for US Prostate Cancer Nuclear Medicine Diagnostics market, the report also offers a full study of the future trends and developments of the market.

The prostate cancer nuclear medicine diagnostics market in the US was valued at US$ 194.47 million in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach US$ 431.76 million by 2027.

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/8703

The prostate cancer nuclear medicine diagnostics market in the US is segmented into type and PET product. Based on type, the market is further segmented into PET and SPECT. The PET segment secured the largest share of the market in 2019. The segment is also forecasted to record the highest growth rate in the market. Based on PET product, the market is further segmented into F-18, C-11, and Ga68-PSMA. The F-18 segment held the largest share of the market in 2019. However, Ga68-PSMA is estimated to register the highest CAGR in the market during the forecast period due to factors such as rising prevalence of prostate cancer, technological improvements in diagnosis systems, and its higher sensitivity and accuracy.

US Prostate Cancer Nuclear Medicine Diagnostics Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2027
US Prostate Cancer Nuclear Medicine Diagnostics Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2027

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/8703

Driving factors of the prostate cancer nuclear medicine diagnostics market are rising prevalence of prostate cancer and the growth of innovative radiopharmaceuticals. However, factors such as strict guidelines for storage, production, and use of radiopharmaceuticals are likely to restrain the growth of the market during the forecast period.

Global US Prostate Cancer Nuclear Medicine Diagnostics Market: Drivers and Restraints: This section of the US Prostate Cancer Nuclear Medicine Diagnostics Market Analysis report we are covering various drivers and restraints that have affected the global US Prostate Cancer Nuclear Medicine Diagnostics market. The complete study of plentiful drivers of the market enables market professionals to get a clear viewpoint of the US Prostate Cancer Nuclear Medicine Diagnostics market share, which consists of US Prostate Cancer Nuclear Medicine Diagnostics industry environment, advancement market, product innovations, latest developments, and US Prostate Cancer Nuclear Medicine Diagnostics market risks.

Prostate cancer (PCa) is the fourth common cancer across the US in terms of occurrence. The rising prevalence of prostate cancer in the country led to the increased use of nuclear medicines for its treatment. For instance, according to GLOBOCAN, in 2018, there were ~2,129,118 cases of cancer in the US. Among these cases, about 10% were prostate cancer, i.e., 212,783 incidences in 2018. Moreover, the country reported 28,705 deaths due to cancer. The organization has estimated the cases of prostate cancer to reach above 737,463 in the next 5 years. After skin cancer, prostate cancer is the most common cancer in the American male population. As per the data of the American Cancer Society, 2020, it was estimated that prostate cancer would be about 191,930 and can result in deaths of ~33,330 people from prostate cancer in the US in 2020. Prostate cancer is more likely to grow in older adults. Thus, the rising incidences of prostate cancer offer huge growth opportunities for the prostate cancer nuclear medicine diagnostics market during the forecast period.

A few major primary and secondary references included in the report are Food and Drug Administration, World Health Organization (WHO), US Nuclear Regulatory Commission (NRC), American Cancer Society, and Centers for Medicare and Medicaid Services, Center for Drug Evaluation and Research (CDER).

Some of the Highlights about Table of Content of US Prostate Cancer Nuclear Medicine Diagnostics Market

1 US Prostate Cancer Nuclear Medicine Diagnostics Market overview

  • Market Introduction
  • Research Objectives
  • Years Considered
  • US Prostate Cancer Nuclear Medicine Diagnostics Market Research Methodology
  • Economic Indicators
  • Currency Considered

2 Executive Summary

  • World Market Overview
  • Global US Prostate Cancer Nuclear Medicine Diagnostics Consumption analysis and forecast
  • US Prostate Cancer Nuclear Medicine Diagnostics Consumption CAGR by Region

3 Market Drivers, Challenges and Trends

  • US Prostate Cancer Nuclear Medicine Diagnostics Market Drivers and Impact
  • Growing Demand from Key Regions
  • Growing Demand from Key Applications and Potential Industries
  • Market Challenges and Impact
  • US Prostate Cancer Nuclear Medicine Diagnostics Market Trends

4 Marketing, Distributors and Customer

  • Sales Channel
  • Direct Channels
  • Indirect Channels

5 Key Players Analysis

  • Company Details
  • Main Business Overview
  • Product Benchmarking
  • Recent Developments and Technological Advancement in US Prostate Cancer Nuclear Medicine Diagnostics Market

Request Customization on This Report @ https://www.cuereport.com/request-for-customization/8703

About the author

Market Study Report

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.